World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
67
Citations
42919
World Ranking
8018
National Ranking
3631

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Genetics
  • Internal medicine

His primary areas of study are Genetics, Genome-wide association study, Immunology, Inflammatory bowel disease and Ulcerative colitis. His biological study deals with issues like IRGM, which deal with fields such as Interleukin-23 receptor. His study in Genome-wide association study is interdisciplinary in nature, drawing from both Odds ratio, Genotyping, Case-control study and Locus.

His Locus research focuses on Candidate gene and how it connects with Genetic linkage, Genome, Human genome and Expression quantitative trait loci. His studies deal with areas such as Allele and NOD2 as well as Inflammatory bowel disease. His Ulcerative colitis research is multidisciplinary, incorporating elements of Crohn's disease and Diarrhea.

His most cited work include:

  • A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease (4248 citations)
  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (3117 citations)
  • A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (2526 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Genetics, Inflammatory bowel disease, Ulcerative colitis, Immunology and Crohn's disease. All of his Genetics and Genome-wide association study, Locus, Genetic association, Single-nucleotide polymorphism and Linkage disequilibrium investigations are sub-components of the entire Genetics study. Disease covers Richard H. Duerr research in Inflammatory bowel disease.

His Ulcerative colitis study combines topics in areas such as Odds ratio, Colitis, Primary sclerosing cholangitis, Genetic heterogeneity and Cohort. His Immunology research incorporates elements of Family aggregation, Genetic predisposition and NOD2. His studies examine the connections between Crohn's disease and genetics, as well as such issues in Gastroenterology, with regards to Ileal resection.

He most often published in these fields:

  • Genetics (47.68%)
  • Inflammatory bowel disease (38.41%)
  • Ulcerative colitis (39.07%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (16.56%)
  • Gastroenterology (12.58%)
  • Crohn's disease (28.48%)

In recent papers he was focusing on the following fields of study:

Richard H. Duerr mainly investigates Internal medicine, Gastroenterology, Crohn's disease, Ileal resection and Exome sequencing. He has researched Crohn's disease in several fields, including Post operative and Period. The Ileal resection study which covers Perioperative that intersects with Gene expression.

His work deals with themes such as Genome-wide association study, Immunology and Rare disease, which intersect with Exome sequencing. His Genome-wide association study study is concerned with the field of Genetics as a whole. His research on Rare disease also deals with topics like

  • Gene which intersects with area such as Inflammatory bowel disease,
  • Missing heritability problem that connect with fields like Disease.

Between 2017 and 2021, his most popular works were:

  • Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease. (132 citations)
  • Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population (43 citations)
  • NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease (34 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Genetics

The scientist’s investigation covers issues in Allele frequency, Genome-wide association study, Exome sequencing, Mixture model and Genetic variation. His Allele frequency study integrates concerns from other disciplines, such as Ashkenazi jews, Kinase activity, Immunology and LRRK2. His Genome-wide association study study frequently intersects with other fields, such as Haplotype.

His Mixture model research is multidisciplinary, incorporating perspectives in Transcriptome, Computational biology, Cluster analysis and Genomics. His Genetic variation study necessitates a more in-depth grasp of Genetics.

Best Publications

  • A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

    Yasunori Ogura;Denise K. Bonen;Naohiro Inohara;Dan L. Nicolae

  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr

  • A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

    Richard H. Duerr;Kent D. Taylor;Steven R. Brant;Steven R. Brant;John D. Rioux;John D. Rioux

  • Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

    Jeffrey C. Barrett;Sarah Hansoul;Dan L. Nicolae;Judy H. Cho

  • Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

    Andre Franke;Dermot P B McGovern;Jeffrey C. Barrett;Kai Wang

  • Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

    John D. Rioux;John D. Rioux;Ramnik J. Xavier;Kent D. Taylor;Mark S. Silverberg

  • Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

    Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke

  • Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease

    Gosia Trynka;Karen A Hunt;Nicholas A Bockett;Jihane Romanos

  • Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.

    Manuel A. Rivas;Manuel A. Rivas;Manuel A. Rivas;Mélissa Beaudoin;Agnes Gardet;Christine Stevens

  • Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease.

    Steven A McCarroll;Alan Huett;Petric Kuballa;Shannon D Chilewski

  • Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

    Isabelle Cleynen;Isabelle Cleynen;Gabrielle Boucher;Luke Jostins;Luke Jostins;Luke Jostins;L Philip Schumm

  • Genome-wide association identifies multiple ulcerative colitis susceptibility loci

    Dermot P.B. McGovern;Agnès Gardet;Leif Törkvist;Philippe Goyette

  • Fine-mapping inflammatory bowel disease loci to single-variant resolution

    Hailiang Huang;Hailiang Huang;Ming Fang;Luke Jostins;Maša Umićević Mirkov

  • Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.

    Denise K. Bonen;Yasunori Ogura;Dan L. Nicolae;Naohiro Inohara

  • Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study

    Mark S. Silverberg;Judy H. Cho;John D. Rioux;Dermot P B McGovern

  • Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis

    Amir S. Karban;Toshihiko Okazaki;Carolien I.M. Panhuysen;Thomas Gallegos

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: Comparison with other colitides/ diarrheal illnesses

    Richard H. Duerr;Richard H. Duerr;Stephan R. Targan;Stephan R. Targan;Carol J. Landers;Carol J. Landers;Lloyd R. Sutherland;Lloyd R. Sutherland

  • Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis

    Richard H. Duerr;Richard H. Duerr;Stephan R. Targan;Stephan R. Targan;Carol J. Landers;Carol J. Landers;Nicholas F. Larusso;Nicholas F. Larusso

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Judy H. Cho
Judy H. Cho Icahn School of Medicine at Mount Sinai
John D. Rioux
John D. Rioux University of Montreal
Steven R. Brant
Steven R. Brant Rutgers, The State University of New Jersey
Mark S. Silverberg
Mark S. Silverberg University of Toronto
Dermot P.B. McGovern
Dermot P.B. McGovern Cedars-Sinai Medical Center
Mark J. Daly
Mark J. Daly Massachusetts General Hospital
Talin Haritunians
Talin Haritunians Cedars-Sinai Medical Center
Kent D. Taylor
Kent D. Taylor David Geffen School of Medicine at UCLA
Stephan R. Targan
Stephan R. Targan Cedars-Sinai Medical Center
Ramnik J. Xavier
Ramnik J. Xavier Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard H. Duerr

Trending Scientists

Recently Published Articles